Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farhad Pazan

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Drugs - Real World Outcomes|March 17, 2022
The Sex-Specific Impact of the FORTA (Fit-fOR-The-Aged) List on Medication Quality and Clinical Endpoints in Older Hospitalized Patients: Secondary Analysis of a Randomized Controlled TrialAnn-Kathrin Schmitt, Christel Weiss, Heinrich Burkhardt, et al.
Age and Ageing|January 21, 2016
VALFORTA: a randomised trial to validate the FORTA (Fit fOR The Aged) classificationMartin Wehling, Heinrich Burkhardt, Alexandra Kuhn-Thiel, et al.
European Journal of Clinical Pharmacology|December 3, 2017
Changes in prescription patterns in older hospitalized patients: the impact of FORTA on disease-related over- and under-treatmentsFarhad Pazan, Heinrich Burkhardt, Helmut Frohnhofen, et al.
Drugs & Aging|December 23, 2018
Higher Fit-fOR-The-Aged (FORTA) Scores Comprising Medication Errors are Associated with Impaired Cognitive and Physical Function Tests in the VALFORTA TrialFarhad Pazan, Heinrich Burkhardt, Helmut Frohnhofen, et al.
Plos One|October 8, 2011
Universal stress proteins are important for oxidative and acid stress resistance and growth of Listeria monocytogenes EGD-e in vitro and in vivoChrista Seifart Gomes, Benjamin Izar, Farhad Pazan, et al.
Drugs & Aging|June 6, 2020
A Structured Literature Review and International Consensus Validation of FORTA Labels of Oral Anticoagulants for Long-Term Treatment of Atrial Fibrillation in Older Patients (OAC-FORTA 2019)Farhad Pazan, Ronan Collins, Victor M Gil, et al.
Drugs & Aging|June 7, 2024
Validation of MyFORTA: An Automated Tool to Improve Medications in Older People Based on the FORTA ListMartin Wehling, Johannes Weindrich, Christel Weiss, et al.
Drugs & Aging|April 13, 2021
International Validation of the Turkish Inappropriate Medication Use in the Elderly (TIME) Criteria Set: A Delphi Panel StudyGülistan Bahat, Birkan Ilhan, Tugba Erdogan, et al.
European Journal of Clinical Pharmacology|September 27, 2022
Higher FORTA (Fit fOR The Aged) scores are associated with poor functional outcomes, dementia, and mortality in older peopleFarhad Pazan, Hanna Breunig, Christel Weiss, et al.
Drugs & Aging|May 2, 2026
Longitudinal Non-interventional Changes of the FORTA Score are Associated with Changes of Cognitive and Physical Function Tests in Community-Dwelling Older PeopleFarhad Pazan, Julia Knorr, Christel Weiss, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Drugs - Real World Outcomes|March 17, 2022
The Sex-Specific Impact of the FORTA (Fit-fOR-The-Aged) List on Medication Quality and Clinical Endpoints in Older Hospitalized Patients: Secondary Analysis of a Randomized Controlled TrialAnn-Kathrin Schmitt, Christel Weiss, Heinrich Burkhardt, et al.
Age and Ageing|January 21, 2016
VALFORTA: a randomised trial to validate the FORTA (Fit fOR The Aged) classificationMartin Wehling, Heinrich Burkhardt, Alexandra Kuhn-Thiel, et al.
European Journal of Clinical Pharmacology|December 3, 2017
Changes in prescription patterns in older hospitalized patients: the impact of FORTA on disease-related over- and under-treatmentsFarhad Pazan, Heinrich Burkhardt, Helmut Frohnhofen, et al.
Drugs & Aging|December 23, 2018
Higher Fit-fOR-The-Aged (FORTA) Scores Comprising Medication Errors are Associated with Impaired Cognitive and Physical Function Tests in the VALFORTA TrialFarhad Pazan, Heinrich Burkhardt, Helmut Frohnhofen, et al.
Plos One|October 8, 2011
Universal stress proteins are important for oxidative and acid stress resistance and growth of Listeria monocytogenes EGD-e in vitro and in vivoChrista Seifart Gomes, Benjamin Izar, Farhad Pazan, et al.
Drugs & Aging|June 6, 2020
A Structured Literature Review and International Consensus Validation of FORTA Labels of Oral Anticoagulants for Long-Term Treatment of Atrial Fibrillation in Older Patients (OAC-FORTA 2019)Farhad Pazan, Ronan Collins, Victor M Gil, et al.
Drugs & Aging|June 7, 2024
Validation of MyFORTA: An Automated Tool to Improve Medications in Older People Based on the FORTA ListMartin Wehling, Johannes Weindrich, Christel Weiss, et al.
Drugs & Aging|April 13, 2021
International Validation of the Turkish Inappropriate Medication Use in the Elderly (TIME) Criteria Set: A Delphi Panel StudyGülistan Bahat, Birkan Ilhan, Tugba Erdogan, et al.
European Journal of Clinical Pharmacology|September 27, 2022
Higher FORTA (Fit fOR The Aged) scores are associated with poor functional outcomes, dementia, and mortality in older peopleFarhad Pazan, Hanna Breunig, Christel Weiss, et al.
Drugs & Aging|May 2, 2026
Longitudinal Non-interventional Changes of the FORTA Score are Associated with Changes of Cognitive and Physical Function Tests in Community-Dwelling Older PeopleFarhad Pazan, Julia Knorr, Christel Weiss, et al.
Pageof 3